Scarica l'app Stockscreener
95.31
0.12%
0.11
Dopo l'orario di chiusura:
95.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$95.20
Aprire:
$95.3
Volume 24 ore:
242.08K
Relative Volume:
0.70
Capitalizzazione di mercato:
$3.15B
Reddito:
$2.32B
Utile/perdita netta:
$82.93M
Rapporto P/E:
37.82
EPS:
2.52
Flusso di cassa netto:
$203.54M
1 W Prestazione:
-0.72%
1M Prestazione:
+3.56%
6M Prestazione:
-1.45%
1 anno Prestazione:
+0.80%
Intervallo 1D:
$95.20
$95.53
Intervallo di 1 settimana:
$95.13
$96.92
Portata 52W:
$82.15
$98.95
Amedisys Inc Stock (AMED) Company Profile
Nome
Amedisys Inc
Settore
Industria
Telefono
(225) 292-2031
Indirizzo
3854 AMERICAN WAY, BATON ROUGE, LA
Confronta AMED con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
95.31 | 3.15B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
353.70 | 83.71B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
28.39 | 15.02B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
148.83 | 13.75B | 20.97B | 3.13B | 2.39B | 31.21 |
|
EHC
Encompass Health Corp
|
116.41 | 11.76B | 5.22B | 422.40M | 269.50M | 4.14 |
|
UHS
Universal Health Services Inc
|
181.78 | 11.65B | 15.42B | 1.03B | 956.84M | 15.02 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-07-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-07 | Downgrade | Truist | Buy → Hold |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-03-13 | Iniziato | Barclays | Equal Weight |
| 2022-10-27 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-08-02 | Downgrade | UBS | Neutral → Sell |
| 2022-06-29 | Iniziato | Stifel | Hold |
| 2022-06-21 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-01 | Aggiornamento | UBS | Sell → Neutral |
| 2022-02-25 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-02-25 | Reiterato | Credit Suisse | Outperform |
| 2022-02-25 | Reiterato | Oppenheimer | Outperform |
| 2022-02-25 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-02-25 | Reiterato | Raymond James | Outperform |
| 2022-02-25 | Reiterato | Truist | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-09-24 | Iniziato | UBS | Sell |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-10 | Reiterato | The Benchmark Company | Buy |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-08-20 | Ripresa | Barclays | Overweight |
| 2020-07-30 | Reiterato | The Benchmark Company | Buy |
| 2020-06-18 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-05-07 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-03-09 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-01-17 | Iniziato | Credit Suisse | Outperform |
| 2019-11-01 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-10-22 | Ripresa | Stephens | Equal-Weight |
| 2019-09-17 | Iniziato | Deutsche Bank | Buy |
| 2019-05-02 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-12-14 | Iniziato | Barclays | Equal Weight |
| 2018-11-16 | Iniziato | UBS | Neutral |
| 2018-10-30 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2018-07-03 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-03-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-11-09 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-11-09 | Downgrade | The Benchmark Company | Buy → Hold |
| 2017-11-08 | Reiterato | Mizuho | Buy |
| 2017-11-02 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2017-08-21 | Iniziato | BofA/Merrill | Neutral |
Mostra tutto
Amedisys Inc Borsa (AMED) Ultime notizie
Amedisys Executive Makes Notable Stock Sale - TipRanks
US magistrate judge schedules UnitedHealth, Optum-Amedisys mediation conference - MLex
What Mediation Means For The UnitedHealth Group, Amedisys Deal - Home Health Care News
Director Kline Teresa L. was granted 1,690 shares, increasing direct ownership by 21% to 9,818 units (SEC Form 4) - Quantisnow
Director Capps Vickie L was granted 1,690 shares, increasing direct ownership by 21% to 9,818 units (SEC Form 4) - Quantisnow
Director Samuels Ivanetta Davis was granted 1,690 shares, increasing direct ownership by 29% to 7,600 units (SEC Form 4) - Quantisnow
UnitedHealth, Amedisys reach new deal to sell home health and hospice locations if merger approved - Healthcare Dive
Amedisys Deal Would Bring BrightSpring Into Range of New Markets - Hospice News
UnitedHealth, Amedisys strike deals to sell home care locations - Modern Healthcare
Amedisys, Inc. to Host Earnings Call - ACCESS Newswire
Amedisys to Divest Hospice, Home Health Locations to BrightSpring, The Pennant Group - Hospice News
Amedisys (AMED) Boosts Sale Prospects with Divestiture Plan - GuruFocus
Amedisys gains after announcing new divestiture agreements in UnitedHealth deal - Seeking Alpha
Decoding Amedisys Inc (AMED): A Strategic SWOT Insight - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
UnitedHealth: Q1 Decline Makes Undervalued Stock a Strong Buy With Dividend Upside - Investing.com
AMEDISYS INC SEC 10-Q Report - TradingView
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise - TradingView
Amedisys: Q1 Earnings Snapshot - MySA
Amedisys Reports Strong Q1 2025 Financial Results - TipRanks
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
AMEDISYS Earnings Results: $AMED Reports Quarterly Earnings - Nasdaq
Amedisys Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Amedisys (AMED) Tops Q1 Earnings Estimates - Yahoo Finance
Amedisys Inc Q1 2025 Earnings: EPS of $1.84 Beats Estimates, Rev - GuruFocus
Amedisys Reports First Quarter 2025 Financial Results - The Manila Times
Amedisys Extends Credit Facility Amid Merger Talks - TipRanks
Amedisys Q1 Profit Increases, Beats Estimates - Nasdaq
Amedisys Reports First Quarter 2025 Financial Results | AMED Sto - GuruFocus
Earnings Flash (AMED) AMEDISYS INC. Reports Q1 Adjusted EPS $1.25, vs. FactSet Est of $1.11 - marketscreener.com
Amedisys, Inc. Reports Strong Q1 2025 Financial Results with Significant Revenue and Net Income Growth - Nasdaq
US settlement talks begin in UnitedHealth-Amedisys merger case - MLex
Amedisys: 2Q Earnings Snapshot - marketscreener.com
Amedisys (AMED) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
UnitedHealth to enter mediation with DOJ over Amedisys deal - Healthcare Dive
DOJ, UnitedHealth-Amedisys lawsuit headed to mediation - Modern Healthcare
DOJ's Lawsuit Against Amedisys, UnitedHealth Group Set for Mediation - Hospice News
Shareholder Alert: Ademi LLP investigates whether Amedisys, Inc. has obtained a Fair Price in its transaction with Option Care Health - marketscreener.com
Amedisys Gets Merger Filing Claim Paused In DOJ's UHG Suit - Law360
Monthly Merger Review Snapshot - Law360
Cantor Fitzgerald maintains Amedisys stock at Neutral, $101 target By Investing.com - Investing.com Canada
Lobbying Update: $50,000 of AMEDISYS HOME HEALTH AND HOSPICE CARE lobbying was just disclosed - Nasdaq
Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report? - Yahoo Finance
Amedisys’ home health volume increases by 5% for Q4 2020 as profits soar by 63% - McKnight's Senior Living
Oppenheimer moving to Perform from Not Rated on Amedisys - TipRanks
US Bancorp DE Boosts Holdings in Amedisys, Inc. (NASDAQ:AMED) - Defense World
Raymond James maintains Amedisys stock Market Perform rating By Investing.com - Investing.com Canada
Raymond James maintains Amedisys stock Market Perform rating - Investing.com
Amedisys Inc Azioni (AMED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.44%
1.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):